Pfizer investigates new compound in healthy volunteers – no disease involved
NCT ID NCT06659250
First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 29 times
Summary
This early-stage study tested a new medicine called PF-06414300 in 63 healthy adults aged 18 to 65. The goal was to check safety and measure how the drug moves through the body. Participants received either the drug or a placebo in one or two parts of the study. This trial does not aim to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pfizer Clinical Research Unit - New Haven
New Haven, Connecticut, 06511, United States
Conditions
Explore the condition pages connected to this study.